LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry

Furio Colivicchi; Gianna Fabbri; Fabrizio Oliva; Maurizio Giuseppe Abrignani; Marcello Arca; Maurizio Averna; Alberico L. Catapano; Martina Ceseri; Stefania Angela Di Fusco; Andrea Di Lenarda; Francesco Fattirolli; Domenico Gabrielli; Lucio Gonzini; Michele Massimo Gulizia; Carmine Riccio; Pier Luigi Temporelli; Antonio Aloia; Alessandro Alonzo; Daniela Aschieri; Emanuele Barbato; Daniele Bertoli; Paolo Calabrò; Leonardo Calò; Stefano Carugo; Vincenzo Crisci; Giuseppe La Rosa; Simone Maffei; Alessandro Navazio; Daniela Pavan; Nicola Scelza; Pietro Scicchitano; Sakis Themistoclakis; Aldo Maggioni

doi:10.1016/j.ijcard.2025.133290

Related publications

Article2025

To improve the quality of secondary prevention strategies in diabetic patients: the BRING-UP Prevention study results

Aldo Maggioni, Gianna Fabbri, Francesco Fattirolli, Domenico Gabrielli, Lucio Gonzini, Michele Massimo Gulizia, Fabrizio Oliva, Francesco Orso, Carmine Riccio, Pier Luigi Temporelli, F Colivicchi

Article2025

A national project to improve the quality of secondary prevention strategies: the results of the BRING-UP Prevention study

F Colivicchi, Maurizio Giuseppe Abrignani, Marcello Arca, Maurizio Averna, Alberico L. Catapano, Stefania Angela Di Fusco, Andrea Di Lenarda, Gianna Fabbri, Domenico Gabrielli, Donata Lucci, Fabrizio Oliva, Francesco Orso, Aldo Maggioni

Article2025

A NATIONAL PROJECT TO IMPROVE THE QUALITY OF SECONDARY PREVENTION STRATEGIES: THE RESULTS OF THE BRING–UP PREVENTION STUDY

Maurizio Bertaina, F Colivicchi, Maurizio Giuseppe Abrignani, Marcello Arca, Francesco Fattirolli, Andrea Di Lenarda, Fabrizio Oliva, Martina Ceseri, Lucio Gonzini, Gianna Fabbri, Aldo Maggioni

Article2025

Statin intolerance in a real word setting of Italian cardiology centers: data from the BRING-UP Prevention study

Furio Colivicchi, Maurizio Giuseppe Abrignani, Marcello Arca, Maurizio Averna, Alberico L. Catapano, Stefania Angela Di Fusco, Andrea Di Lenarda, Gianna Fabbri, Francesco Fattirolli, Domenico Gabrielli, Michele Massimo Gulizia, Fabrizio Oliva, Carmine Riccio, Pier Luigi Temporelli, Aldo Maggioni

Article2005

W16-P-031 Fluvastatin safety profile in patients with low levels of ldl cholesterol in the Lescol® intervention prevention study

Pedro A. Lemos, Chourmouzios A. Arampatzis, Dick Goedhart, Claudio Gimpelewicz, M. Freudenreich, J.O. Logani, M. Bortolini, Patrick W. Serruys

Atherosclerosis Supplements

LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry

Discussion(0)

Related publications

To improve the quality of secondary prevention strategies in diabetic patients: the BRING-UP Prevention study results

A national project to improve the quality of secondary prevention strategies: the results of the BRING-UP Prevention study

A NATIONAL PROJECT TO IMPROVE THE QUALITY OF SECONDARY PREVENTION STRATEGIES: THE RESULTS OF THE BRING–UP PREVENTION STUDY

Statin intolerance in a real word setting of Italian cardiology centers: data from the BRING-UP Prevention study

W16-P-031 Fluvastatin safety profile in patients with low levels of ldl cholesterol in the Lescol® intervention prevention study